NCT03617861View on ClinicalTrials.gov

Effect of Secretin in Functional Dyspepsia and Healthy Subjects

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

November 7, 2018

Primary Completion Date

July 1, 2019

Study Completion Date

August 1, 2019

Conditions
DyspepsiaHealthy
Interventions
DRUG

Human Secretin

Injected once over one minute

DRUG

Placebo

Injected once over one minute

Trial Locations (1)

55905

Mayo Clinic in Rochester, Rochester

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

lead

Mayo Clinic

OTHER

NCT03617861 - Effect of Secretin in Functional Dyspepsia and Healthy Subjects | Biotech Hunter | Biotech Hunter